Pfizer

Pfizer $PFE ends development of obesity drug due to side effects. 🔴

You may remember my recent post that talked about the positive test results of Pfizer's obesity drug.

Today our stock dropped over 4% right after the market opened on the news that the development of this drug was being abruptly terminated.
Pfizer said it will instead focus on its other oral obesity drug,...
Read more

What sector are you primarily focused on and what sector do you see the most potential in???

My main focus lately has been on the healthcare sector, as I see huge potential there. I think the healthcare sector is still moving forward and will grow even more in the future.

When I look at how many people have some health problems and medicine is needed more and more, or how many...
Read more

Charlie Munger and his view of healthcare in the US.

Charlie, a friend, partner of Warren, has recently been vocal about his concerns about US healthcare, literally stating that it is a system that prolongs death to make more money and comparing patients to African carcasses. 🤔

Pfizer $PFE

Pfizer is a pharmaceutical company that is best known for Viagra and the COVID-19 vaccine.

Full Year 2022 Results :

Revenue : $100.330 billion

Net income : $29.051 billion

EPS : $5.18

Did you buy any stocks this week?

I bought $39 worth of Pfizer $PFE stock and did a little research on their future intentions, where I clearly see growth potential + a regular and stable dividend. What about you?

Lately, it has been mostly technology stocks that have been up a few dozen percent. However, I am wondering what you currently see as potential buying opportunities.

I've been buying stocks recently, $MMM and $DIS. However, I am planning on buying shares of $CVS and $PFE.

Views on the current price and future of Pfizer $PFE?

The company is entering "the most important 18 months in Pfizer's history," CEO Bourla said in February. That's because the company plans to launch or expand the registration of 19 drugs over the next year and a half.

Pfizer $PFE gained more than 4% today. 🟢

That's thanks to the results of a study showing the same, and potentially higher, efficacy of the new oral weight loss pills than competitor Novo Nordisk's popular Ozempic injection.

This is great news as it makes taking it easier and, for many, more affordable. 
However, the tablet will be further tested, but I think there is huge...
Read more

Novavax $NVAX -> which one of you was happy yesterday?

I won't write an article...
Read more

BioNTech $BNTX

BioNTech reported its results yesterday.

This company focuses and specializes in the development and research of immunotherapeutic drugs targeting the treatment of cancer and infectious diseases.

It is also known for the development and production of the COVID-19 vaccine with Pfizer.

Results for the first quarter of this year :

Revenues : EUR 1.28 billion, first...
Read more

Pfizer $PFE

Pfizer reported its quarterly results yesterday.

Sector : Pharmaceuticals.

Focus, specialization : production of drugs for humans and animals and the company also focuses on fighting various diseases such as : cancer, diabetes or Alzheimer's disease.

Products : Viagra or the vaccine against COVID-19.

Results :

Revenues : $18.3 billion

Earnings per share : $1.23

After today's $PFE results, investors are likely to be tough on even competitor $CVS, which will report its results tomorrow before the market opens. So I expect a pullback, which I will use to increase my position. Anything around $70 is a nice price in my opinion. In fact, I don't think $CVS should come up with surprisingly good results.